1. Home
  2. ORIS vs JAGX Comparison

ORIS vs JAGX Comparison

Compare ORIS & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ORIS

Oriental Rise Holdings Limited Ordinary Shares

HOLD

Current Price

$1.52

Market Cap

3.7M

ML Signal

HOLD

Logo Jaguar Health Inc.

JAGX

Jaguar Health Inc.

HOLD

Current Price

$0.92

Market Cap

3.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORIS
JAGX
Founded
2014
2013
Country
China
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.9M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
ORIS
JAGX
Price
$1.52
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$60.00
AVG Volume (30 Days)
180.5K
394.6K
Earning Date
04-30-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$12,317,000.00
$11,785,000.00
Revenue This Year
N/A
$22.41
Revenue Next Year
N/A
$30.00
P/E Ratio
$163.69
N/A
Revenue Growth
N/A
12.45
52 Week Low
$1.14
$0.95
52 Week High
$57.00
$33.25

Technical Indicators

Market Signals
Indicator
ORIS
JAGX
Relative Strength Index (RSI) 96.29 33.96
Support Level $0.06 $1.06
Resistance Level $0.11 $1.15
Average True Range (ATR) 0.05 0.14
MACD 0.13 -0.01
Stochastic Oscillator 85.91 0.53

Price Performance

Historical Comparison
ORIS
JAGX

About ORIS Oriental Rise Holdings Limited Ordinary Shares

Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Share on Social Networks: